Anthracycline derivatives having cytostatic activity

C - Chemistry – Metallurgy – 07 – H

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

167/182, 260/208

C07H 15/252 (2006.01) C07H 15/26 (2006.01)

Patent

CA 1340021

The invention relates to new anthracycline derivatives having cytostatic activity and the general formula I, which can optionally also be in the form of an acid addition salt of physiologically acceptable inorganic or organic acids, where R1 is hydrogen or a hydroxyl group, R2 is hydrogen, a hydroxyl or a methoxy group, R3 is hydrogen or a hydroxyl group, R4 is hydrogen or a hydroxyl group, R5 is hydrogen, a hydroxyl or a methoxycarbonyl group, R6 is CH2CH3, COCH3, COCH2OH, CHOHCH3 or CHOHCH2OH and R7 is an organic substituent which has 2 to 6 carbon atoms and which contains at least one oxygen, nitrogen or sulfur atom or a C-C double bond or a C-C triple bond, it being possible for the double bond also to be a constituent of a heteroaromatic system and for the oxygen, nitrogen or sulfur atom to be a constituent of an open-chain or heterocyclic system, to a process for the preparation thereof and to the use thereof in a pharmaceutical. (see fig. I)

601592

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Anthracycline derivatives having cytostatic activity does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anthracycline derivatives having cytostatic activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anthracycline derivatives having cytostatic activity will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1306275

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.